On March 2, 2021 ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, reported that Jacob Chacko, M.D., chief executive officer, will present a company overview at the following investor conferences in March (Press release, ORIC Pharmaceuticals, MAR 2, 2021, View Source [SID1234575942]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright Global Life Sciences Conference – On-demand pre-recorded company overview available on March 9, 2021 at 7:00 a.m. ET / 4:00 a.m. PT; and

Oppenheimer 31st Annual Healthcare Conference – Presenting company overview on March 16, 2021 at 2:30 p.m. ET / 11:30 a.m. PT.

Webcasts of each presentation will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the events.